Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May:149:112843.
doi: 10.1016/j.biopha.2022.112843. Epub 2022 Mar 21.

Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review

Affiliations
Review

Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review

Talal Almas et al. Biomed Pharmacother. 2022 May.

Abstract

The coronavirus disease 2019 (COVID-19) has overwhelming healthcare systems globally. To date, a myriad of therapeutic regimens has been employed in an attempt to curb the ramifications of a severe COVID-19 infection. Amidst the ongoing pandemic, the advent and efficacious uptake of COVID-19 vaccination has significantly reduced disease-related hospitalizations and mortality. Nevertheless, many side-effects are being reported after COVID-19 vaccinations and myocarditis is the most commonly reported sequelae post vaccination. Majority of these diseases are associated with COVID-19 mRNA vaccines. Various studies have established a temporal relationship between these complications, yet the causality and the underlying pathogenesis remain hypothetical. In this review, we aim to critically appraise the available literature regarding the cardiovascular side effects of the various mRNA vaccines and the associated pathophysiology.

Keywords: COVID-19 mRNA vaccine; COVID-19 myocarditis; COVID-19 perimyocarditis; Coronavirus 2019 (COVID-19); SARS-CoV-2; Takotsubo syndrome.

PubMed Disclaimer

Figures

ga1
Graphical abstract
Fig. 1
Fig. 1
The various cardiovascular complications that have been reported post-COVID-19 mRNA vaccination if.
Fig. 2
Fig. 2
The mechanism of action of COVID-19 mRNA vaccines. TCR: T-cell receptor; MHC-I: major histocompatibility complex I; TAP: trasporter associated with antigen processing; MHC-II: major histocompatibility complex II; APC: antigen presenting cell.

Similar articles

Cited by

References

    1. Ritchie H., Mathieu E., Rodés-Guirao L., 2021. et al. Coronavirus (COVID-19) vaccinations - statistics and research. Our World in Data. 〈https://ourworldindata.org/covid-vaccinations〉. Published March 5, 2020. Accessed 4 December 2021.
    1. Hill E.M., Keeling M.J. Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses. J. R. Soc. Interface. 2021;18(182):20210214. doi: 10.1098/rsif.2021.0214. Epub 2021 Sep 1. PMID: 34465208; PMCID: PMC8437233. - PMC - PubMed
    1. Lopez Bernal J., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Stowe J., Tessier E., Groves N., Dabrera G., Myers R., Campbell C.N.J., Amirthalingam G., Edmunds M., Zambon M., Brown K.E., Hopkins S., Chand M., Ramsay M. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 2021;385(7):585–594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21. PMID: 34289274; PMCID: PMC8314739. - PMC - PubMed
    1. Eckart R.E., Love S.S., Atwood J.E., Arness M.K., Cassimatis D.C., Campbell C.L., Boyd S.Y., Murphy J.G., Swerdlow D.L., Collins L.C., Riddle J.R., Tornberg D.N., Grabenstein J.D., Engler R.J. Department of defense smallpox vaccination clinical evaluation team. incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J. Am. Coll. Cardiol. 2004;44(1):201–205. doi: 10.1016/j.jacc.2004.05.004. PMID: 15234435. - PubMed
    1. Myocarditis and pericarditis after mrna COVID-19 vaccination. Centers for Disease Control and Prevention. 〈https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.h.... Accessed 4 December 2021.